Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN23042419
ISRCTN23042419
Active, not recruiting
未知

Point-of-care antibiotic susceptibility testing to aid urinary tract infection treatment using dip-and test microcapillary devices

niversity of Reading0 sites500 target enrollmentSeptember 29, 2023
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity of Reading
Enrollment
500
Status
Active, not recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 29, 2023
End Date
March 31, 2025
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
niversity of Reading

Eligibility Criteria

Inclusion Criteria

  • •1\. \>18 years old
  • •2\. Suspected urinary tract infection as assessed by a clinician
  • •3\. Able to give informed consent

Exclusion Criteria

  • •1\. \<18 years old
  • •2\. Too ill that taking informed consent would disrupt care
  • •3\. Unable to give informed consent

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Antimicrobial susceptibility surveillance: acute uncomplicated cystitis 2020acute uncomplicated cystitis
JPRN-UMIN000041500Sapporo Medical University School of Medicine400
Not yet recruiting
Not Applicable
Modified Antibiotic Susceptibility TestingHealth Condition 1: A415- Sepsis due to other Gram-negativeorganisms
CTRI/2020/12/029794Antibiotic Resistance Leadership Group
Not yet recruiting
Not Applicable
Fast Antibiotic Susceptibility Testing for Gram Negative Bacteremia Trial (FAST)Health Condition 1: R788- Finding of other specified substances, not normally found in blood
CTRI/2024/04/065949M/s Duke University
Not yet recruiting
Not Applicable
Antibiotic optimization in chronic Kidney Disease patientsHealth Condition 1: A00-B99- Certain infectious and parasitic diseases
CTRI/2023/12/060595Gayatri R Panicker
Active, not recruiting
Phase 1
ASEPTIC - using co-trimoxazole antibiotics to prevent spontaneous bacterial peritonitis in cirrhosisSpontaneous bacterial peritonitis infection in patients with advanced liver diseaseMedDRA version: 20.1Level: LLTClassification code 10061135Term: Spontaneous bacterial peritonitisSystem Organ Class: 100000004862Therapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]
EUCTR2019-000581-38-GBniversity College London Comprehensive Clinical Trials Unit548